Micromachines Webinar | Biofabrication Horizons — May
3rd Edition
the chair
7th Micromachines Webinar
Biofabrication Horizons
Dear Colleagues,
It is my pleasure to launch the new webinar series of the “Biofabrication and Tissue Engineering” section of Micromachines (MDPI). This monthly series is dedicated to fostering global dialogue and collaboration at the forefront of our rapidly evolving discipline.
Each webinar will spotlight groundbreaking advances in 3D and 4D bioprinting, next-generation bioinks, organs-on-chips and microphysiological systems, scaffold-free tissue assembly, advanced biomaterials (including stimuli-responsive hydrogels and decellularized matrices), microfluidics, hybrid micro/nano-fabrication techniques, and translational strategies that bridge the gap between bench and bedside.
By convening leading researchers, clinicians, and industry innovators, we aim to highlight the latest discoveries in disease modeling, drug discovery, regenerative medicine, and the commercialization of biofabricated constructs—ultimately accelerating the delivery of transformative solutions to patients and society.
Micromachines is proud to provide this platform to stimulate interdisciplinary exchange, amplify emerging voices, and drive the field toward clinically impactful innovations in personalized healthcare.
I warmly invite you to join us, share your work, and be part of this exciting journey.
Best Regards,
Mohsen Akbari
Date: 22 May 2026
Time: 6:00 pm CEST | 9:00 am PDT
Webinar ID: 861 3403 8489
Webinar Secretariat: journal.webinar@mdpi.com
Meet Our Speakers
Dr. Mohammad A. Qasaimeh
Division of Engineering, New York University Abu Dhabi, UAE, Research Center for Translational Medical Devices, New York University Abu Dhabi, UAE, Tandon School of Engineering, New York University, USA;
Dr. Mohammad A. Qasaimeh is an Associate Professor of Mechanical Engineering and Bioengineering at New York University Abu Dhabi (NYUAD), and a Global Network Associate Professor in Mechanical and Aerospace Engineering and Biomedical Engineering at NYU Tandon School of Engineering, New York. He also serves as Associate Director (Faculty Scholarship) at the NYUAD Center for Faculty Advancement. He earned his PhD in Biomedical Engineering from McGill University in 2013 and subsequently held postdoctoral research positions at the Massachusetts Institute of Technology and Harvard Medical School (Dana-Farber Cancer Institute). Since joining NYUAD in 2014, he has founded and leads the Advanced Microfluidics and Microdevices Laboratory (AMMLab), where his research focuses on microfluidic biochips and miniaturized biomedical systems for point-of-care diagnostics, precision medicine, and translational biomedical applications. His work has been published in leading journals including Advanced Science, Small, Microsystems & Nanoengineering, and Lab on a Chip. Dr. Qasaimeh has received several recognitions, including the Technology Innovation Pioneers (TIP) Award from the UAE Ministry of Economy and the NYUAD Distinguished Service Award. He currently serves on the editorial boards of multiple international journals and has delivered over 45 keynote and invited lectures worldwide.
In this section, you will find the recordings of this webinar to watch, re-watch and share with your colleagues!
Biofabrication Frontiers
Edited by: Dr. Mohsen Akbari
B2: Biofabrication and Tissue Engineering
The ‘Biofabrication and Tissue Engineering’ section of Micromachines focuses on cutting-edge research and innovation in the design, fabrication, and application of biologically functional constructs for regenerative medicine, disease modeling, and drug discovery, with a strong emphasis on bioprinting technologies, including the development of advanced bioinks, 3D/4D printing techniques, and scaffold-free approaches to the creation of complex, multicellular tissues. It also explores organs on chips, leveraging microfabrication to create physiologically relevant models for studying organ-level functions, disease mechanisms, and drug responses, bridging the gap between traditional models and clinical applications. This section highlights the role of biomaterials, such as smart hydrogels, nanocomposites, and decellularized matrices, in directing cellular behavior, promoting tissue regeneration, and enabling the integration of engineered constructs with host tissues. Additionally, it addresses the critical aspects of commercialization and translation, focusing on scaling up technologies, navigating regulatory pathways, and fostering market adoption to accelerate the transition of biofabrication innovations from the lab to clinical and industrial applications, ultimately advancing human health.
This section welcomes original research articles, reviews, perspectives, and technical notes that contribute to the advancement of biofabrication and tissue engineering, promoting interdisciplinary collaboration and driving the field toward transformative solutions for global healthcare challenges.